FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Fibromyalgia related Press Releases

European CHMP Adopts Negative Opinion on Eli Lilly, Boehringer Ingelheim's Cymbalta for the Treatment of Fibromyalgia

Posted October 24, 2008

European CHMP Adopts Negative Opinion on Eli Lilly, Boehringer Ingelheim's Cymbalta for the Treatment of Fibromyalgia INDIANAPOLIS, Oct. 24 /PRNewswire-FirstCall/ -- The Committee for Medicinal

... Read more...

Forest Laboratories, Cypress Bioscience Fibromyalgia Drug Delayed at FDA

Posted October 20, 2008

Forest Laboratories, Cypress Bioscience Fibromyalgia Drug Delayed at FDA NEW YORK and SAN DIEGO, Oct. 20 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX - News) and Cypress Bioscience,... Read more...

JAZZ PHARMACEUTICALS, INC. ANNOUNCES FINAL PATIENT HAS COMPLETED PHASE III CLINICAL TRIAL OF SODIUM OXYBATE TO TREAT FIBROMYALGI

Posted September 11, 2008

JAZZ PHARMACEUTICALS, INC. ANNOUNCES FINAL PATIENT HAS COMPLETED PHASE III CLINICAL TRIAL OF SODIUM OXYBATE TO TREAT FIBROMYALGIA PALO ALTO, Calif., Sept. 11 -- Jazz Pharmaceuticals, Inc. (Nasdaq:... Read more...

PRESS RELEASE: Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome

Posted November 8, 2007

Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show NEW YORK, Nov. 8  -- Total daily dosages of milnacipran 100 mg and 200 mg... Read more...

PRESS RELEASE: Sosei Drug Misses Goal in Fibromyalgia Trial

Posted September 18, 2007

Sosei Drug Misses Goal in Fibromyalgia Trial TOKYO, September 18 -- Sosei Group Corporation , the biopharmaceutical company, today announces that AD 337, an enantiomer of an approved, centrally... Read more...